Literature DB >> 9691999

Clinical predictors of hypoxaemia in children with pneumonia.

A Smyth1, H Carty, C A Hart.   

Abstract

A prospective study to determine which clinical factors identified children with acute lower respiratory infection who were hypoxaemic and at risk of death was done over a 9-month period on children under 5 years of age admitted to a district hospital in rural Zambia. Of 158 children studied, 55 (35%) were found to be hypoxaemic and 23 (14.6%) died. For the subgroup of children under 1 year of age, a respiratory rate of > 70 was the only significant predictor of hypoxaemia (p < 0.001, sensitivity 63%, specificity 89%). In older children, only the presence of crepitations/bronchial breathing was predictive (p = 0.018, sensitivity 75%, specificity 57%). The likelihood of death was increased in those children with low oxygen saturation (p = 0.021) and poor nutrition (p = 0.007). It is concluded that, on the basis of raised respiratory rate, the WHO guidelines are likely to identify children under 1 year of age who are hypoxaemic. However, it may be necessary to include auscultatory findings in the guidelines to recognize hypoxaemia in older children in order to ensure that they receive appropriate treatment with oxygen. This study demonstrates that hypoxaemia and malnutrition are risk factors for death.

Entities:  

Mesh:

Year:  1998        PMID: 9691999     DOI: 10.1080/02724936.1998.11747923

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  25 in total

1.  British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood.

Authors: 
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

2.  Age related reference ranges for respiration rate and heart rate from 4 to 16 years.

Authors:  L A Wallis; M Healy; M B Undy; I Maconochie
Journal:  Arch Dis Child       Date:  2005-07-27       Impact factor: 3.791

3.  Age related reference ranges of respiratory rate and heart rate for children in South Africa.

Authors:  L A Wallis; I Maconochie
Journal:  Arch Dis Child       Date:  2006-01-06       Impact factor: 3.791

Review 4.  Pneumonia research to reduce childhood mortality in the developing world.

Authors:  J Anthony G Scott; W Abdullah Brooks; J S Malik Peiris; Douglas Holtzman; E Kim Mulholland
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

5.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

6.  Hypoxaemia in acute respiratory and non-respiratory illnesses in neonates and children in a developing country.

Authors:  T Duke; A J Blaschke; S Sialis; J L Bonkowsky
Journal:  Arch Dis Child       Date:  2002-02       Impact factor: 3.791

7.  Children with pneumonia: how do they present and how are they managed?

Authors:  Julia E Clark; Donna Hammal; David Spencer; Fiona Hampton
Journal:  Arch Dis Child       Date:  2007-01-29       Impact factor: 3.791

8.  Hypoxemia in children with pneumonia and its clinical predictors.

Authors:  Sudha Basnet; Ramesh Kant Adhikari; Chitra Kumar Gurung
Journal:  Indian J Pediatr       Date:  2006-09       Impact factor: 1.967

9.  Effect of routine zinc supplementation on pneumonia in children aged 6 months to 3 years: randomised controlled trial in an urban slum.

Authors:  Nita Bhandari; Rajiv Bahl; Sunita Taneja; Tor Strand; Kåre Mølbak; Rune Johan Ulvik; Halvor Sommerfelt; Maharaj K Bhan
Journal:  BMJ       Date:  2002-06-08

10.  Case management of childhood pneumonia in developing countries.

Authors:  Philip Ayieko; Mike English
Journal:  Pediatr Infect Dis J       Date:  2007-05       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.